Investor alert: law offices of howard g. smith announces investigation of omeros corporation (omer) on behalf of investors

Bensalem, pa.--(business wire)---- $omer #classaction--law offices of howard g. smith announces an investigation on behalf of omeros corporation (“omeros” or the “company”) (nasdaq: omer) investors concerning the company's possible violations of federal securities laws. on october 1, 2021, omeros announced that the u.s. food and drug administration (“fda”) had identified deficiencies with the company's biologics license application for its drug candidate narsoplimab in the treatment of hematopoietic stem cell transpl
OMER Ratings Summary
OMER Quant Ranking